Skip to content

KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain

Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00224588
Enrollment
80
Registered
2005-09-23
Start date
2003-01-31
Completion date
2005-05-31
Last updated
2006-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Post Thoracotomy Pain, Ketamine, Neuralgia, Pain, Thoracotomy

Keywords

Ketamine, Chronic post thoracotomy pain, NMDA, Post operative

Brief summary

We assessed the effects of the N Methyl aspartate receptor antagonist Ketamine on long-term post thoracotomy pain. We hypothesized that ketamine could prevent supersensitization of the central nervous system involved in this chronic neuropathic pain.

Detailed description

In this clinical, randomized prospective study, peri operative administration of ketamine was compared to placebo on long term post thoracotomy pain after a 2 months follow up period.

Interventions

DRUGKetamine (or placebo : isotonic saline solution)

Sponsors

Direction Régionale de la Recherche Clinique D'ILE DE FRANCE
CollaboratorUNKNOWN
Clinical Research Unit
CollaboratorAMBIG
European Georges Pompidou Hospital
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
80 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients eligible for thoracotomy or pneumectomy

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Long term (2 months) post thoracotomy pain was assessed using a french equivalent of the Mc Gill Pain score and pain area measurements in both groups

Secondary

MeasureTime frame
Analogic pain scores at rest and after coughing

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026